Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$223.05 - $302.68 $29,442 - $39,953
-132 Reduced 49.81%
133 $38,000
Q1 2023

Apr 20, 2023

BUY
$175.41 - $217.92 $46,483 - $57,748
265 New
265 $57,000
Q3 2022

Oct 17, 2022

SELL
$195.21 - $310.53 $225,662 - $358,972
-1,156 Reduced 46.78%
1,315 $366,000
Q2 2022

Aug 02, 2022

BUY
$115.91 - $214.48 $286,413 - $529,980
2,471 New
2,471 $472,000
Q4 2021

Feb 14, 2022

SELL
$165.13 - $241.83 $564,084 - $826,091
-3,416 Closed
0 $0
Q3 2021

Oct 29, 2021

SELL
$163.99 - $235.57 $29,682 - $42,638
-181 Reduced 5.03%
3,416 $703,000
Q2 2021

Aug 11, 2021

SELL
$131.45 - $201.49 $105,291 - $161,393
-801 Reduced 18.21%
3,597 $682,000
Q1 2021

May 11, 2021

BUY
$92.73 - $142.05 $407,826 - $624,735
4,398 New
4,398 $573,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.